51ÔÚÏß

Private equity (PE) investment has continued to play a substantial role in the healthcare M&A market. In the second quarter of 2024, there were 186 deals completed by PE companies or their sponsored companies (PE buyers, collectively), or approximately 38% of all the 496 announced healthcare deals, according to new data captured in the LevinPro HC database. This is a 24% increase from the first quarter of 2024 when 150 acquisitions from PE buyers were announced. Activity in Q2:24 represents a 17% decrease from Q2:23 when 224 PE buyer transactions were reported.

NEW CANAAN, Conn., July 16, 2024 /PRNewswire-PRWeb/ -- Private equity (PE) investment has continued to play a substantial role in the healthcare M&A market. In the second quarter of 2024, there were 186 deals completed by PE companies or their sponsored companies (PE buyers, collectively), or approximately 38% of all the 496 announced healthcare deals, according to new data captured in the LevinPro HC database. This is a 24% increase from the first quarter of 2024 when 150 acquisitions from PE buyers were announced. Activity in Q2:24 represents a 17% decrease from Q2:23 when 224 PE buyer transactions were reported.

In Q2:24, 10 transactions with a PE buyer had a disclosed price. The ten deals totaled more than $5.49 billion in announced spending. The deal with the largest purchase price was Thomas H. Lee Partner, L.P.'s acquisition of Agiliti, Inc., which is a medical equipment company, and was valued at $2.5 billion. The second largest transaction in terms of purchase price was the acquisition of Model N, a revenue cycle management organization, by Vista Equity Partners for $1.25 billion.

Physician Medical Groups (PMG) drew the highest level of activity from PE buyers with 77 deals, accounting for nearly 41% of activity from PE. This is a slight increase from Q1:24 when PE groups and their portfolio companies completed 72 PMG transactions and a minor increase from Q4:23 when PE firms and/or their portfolio companies completed 75 PMG deals. This indicates that PE's involvement in the PMG space is stable, albeit growing at a slow rate.

In the PMG sector, PE groups targeted dental practices in 57% of the acquisitions, with 44 transactions. This is on par with Q1:24 when there were 45 dental transactions completed by a PE buyer. The second most popular PMG specialty for investors was dermatology, with five deals. In the first quarter of 2024, there were four acquisitions targeting dermatology practices.

The most active PE-backed buyer was MB2 Dental Solutions, a portfolio company of Charlesbank Capital Partners, with 23 deals in Q2:24. This marks a small increase from the first quarter of the year when MB2 Dental announced 20 transactions. The second most active PE buyer was Specialized Dental Partners (SDP), backed by Quad-C Management, Inc. which reported eight transactions.

In addition to PMGs, there was a significant amount of PE involvement in the eHealth space, with 24 deals reported during the second quarter of 2024. This is a minor increase from Q1:24 when 20 transactions were announced, yet a decrease from Q2:23 when 28 eHealth acquisitions were reported. The most active eHealth subsector in Q2:24 was medical practice management software with eight completed transactions. The most active eHealth buyer was Serent Capital, which completed two deals; it purchased Medical Informatics Engineering and Traumasoft, both for undisclosed prices.

In Q2:24, there were 12 PE-backed Home Health & Hospice transactions, 10 Medical Devices deals, four Rehabilitation acquisitions and three Pharmaceutical deals.

"It's clear industry headwinds and regulatory pressures are forcing private investors to slow down M&A activity," said Dylan Sammut, Editor of Healthcare at LevinPro HC, which publishes the data. "But even so, private equity remains a dominant force in the healthcare investment space. When market conditions improve, we expect a flurry of activity in the future."

All quarterly results are published in The Health Care M&A Report, which is part of LevinPro HC, a research intelligence platform published by Irving Levin Associates, LLC. For information, or to order the reports, call 800-248-1668. Irving Levin Associates is celebrating more than 70 years of delivering exclusive M&A intelligence to its sophisticated audience of seniors housing and healthcare investors. The company was established in 1948 and has offices in New Canaan, Connecticut and North Bethesda, Maryland. The company publishes research reports and newsletters and maintains databases on the healthcare and senior housing M&A markets.

Media Contact

Dylan Sammut, Irving Levin Associates, 203-846-6800, [email protected],

SOURCE Irving Levin Associates